Overview
- A St. Louis jury unanimously ruled for Bayer-owned Monsanto on Oct. 29, 2026 in the first case to reach a verdict after the U.S. Supreme Court narrowed failure‑to‑warn claims.
- The three plaintiffs, Theresa Aretino, Cynthia Fernandez and Betty Larkin, had argued regular Roundup use led to non‑Hodgkin lymphoma; Fernandez died before the trial and the women are not part of Bayer's proposed settlement.
- Plaintiffs have shifted to claims such as product design defect and negligence because the Supreme Court held that federal law requires herbicide labels to match EPA‑approved labels and the EPA says Roundup's label need not carry a cancer warning.
- Bayer is asking a Missouri state court to approve a $7.25 billion deal to resolve tens of thousands of cases, but many claims remain outside the proposed settlement and the judge has not ruled.
- Scientific and regulatory views remain split — the IARC labeled glyphosate 'probably carcinogenic' in 2015 while the EPA has previously found it probably not carcinogenic and is conducting a new safety review — and the litigation has already cost Bayer more than $10 billion.